Eucomed raises objections to EMA combination guidance involving NBs
This article was originally published in Clinica
The European Medicines Agency’s proposed revised version of its guidance concerning the CE marking of drug/device combination products does not improve the length of the procedure nor the related costs, says European medtech trade association, Eucomed.
You may also be interested in...
Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.